Related Experiment Video

Updated: Sep 28, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Lipid lowering: another method of reducing blood pressure?

A S Wierzbicki1

  • 1Department of Chemical Pathology, St Thomas' Hospital, London, UK.

Journal of Human Hypertension
|November 22, 2002
PubMed

Insights

Lipid-lowering drugs like statins and fibrates may help lower blood pressure in patients with hypertension. Further large-scale trials are needed to confirm these cardiovascular risk reduction effects.

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Cardiovascular risk management relies on assessing risk factors like hypertension and hyperlipidaemia.
  • Hypertension and hyperlipidaemia share common pathogenic pathways, including insulin resistance and endothelial dysfunction.
  • These synergistic risk factors significantly increase the likelihood of cardiovascular events.

Purpose of the Study:

  • To review common pathways linking dyslipidaemia and hypertension.
  • To examine the impact of diet and lipid-lowering drugs on blood pressure in patients with essential hypertension.
  • To explore the potential of lipid-lowering as an additional antihypertensive strategy.

Main Methods:

  • Literature review of common pathogenic mechanisms.
  • Analysis of existing clinical trial data on lipid-lowering drugs and blood pressure.
  • Examination of effects on arterial wall structure and pulse wave velocity.

Main Results:

  • Statins and fibrates demonstrated blood pressure reduction (up to 8/5 mmHg and 15/10 mmHg, respectively) in small trials.
  • Lipid-lowering drugs affect arterial wall structure and pulse wave velocity.
  • These effects may contribute to the observed cardiovascular risk reduction by lipid-lowering therapies.

Conclusions:

  • Lipid lowering may offer an additional benefit for hypertension management in high-risk individuals.
  • Current large-scale trial data on antihypertensive effects of lipid-lowering drugs are limited or inconclusive.
  • Large-scale trials are necessary to definitively establish the antihypertensive efficacy of lipid-lowering drugs.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...